Survey of cannabis use in patients with amyotrophic lateral sclerosis. - Wikidata - awgldk - TriplyDB

Survey of cannabis use in patients with amyotrophic lateral sclerosis.

Survey of cannabis use in patients with amyotrophic lateral sclerosis.

http://www.wikidata.org/entity/Q39382412

about

Narrative review of the safety and efficacy of marijuana for the treatment of commonly state-approved medical and psychiatric disorders Drug therapy for pain in amyotrophic lateral sclerosis or motor neuron disease Drug therapy for pain in amyotrophic lateral sclerosis or motor neuron disease Cannabinoids in health and disease Pain in Neurodegenerative Disease: Current Knowledge and Future Perspectives Complementary and Alternative Therapies in Amyotrophic Lateral Sclerosis An Overview of Potential Targets for Treating Amyotrophic Lateral Sclerosis and Huntington's Disease Cannabis in palliative medicine: improving care and reducing opioid-related morbidity.Antidepressant-like activity and modulation of brain monoaminergic transmission by blockade of anandamide hydrolysis.Medical marijuana in neurology.Palliative Care Issues in Amyotrophic Lateral Sclerosis: An Evidenced-Based Review.ALSUntangled No. 16: cannabis.Cannabinoids: new promising agents in the treatment of neurological diseases.Comprehensive Review of Medicinal Marijuana, Cannabinoids, and Therapeutic Implications in Medicine and Headache: What a Long Strange Trip It's Been ….Cannabinoids in Neurodegenerative Disorders and Stroke/Brain Trauma: From Preclinical Models to Clinical Applications.Neuroprotection in Oxidative Stress-Related Neurodegenerative Diseases: Role of Endocannabinoid System Modulation.Therapeutic approach to pain in neurodegenerative diseases: current evidence and perspectives.Pros and Cons of Medical Cannabis use by People with Chronic Brain Disorders.Can cannabinoids be a potential therapeutic tool in amyotrophic lateral sclerosis?Evaluation of herbal cannabis characteristics by medical users: a randomized trial.Re-branding cannabis: the next generation of chronic pain medicine?Cannabis and amyotrophic lateral sclerosis: hypothetical and practical applications, and a call for clinical trials.Cannabinol delays symptom onset in SOD1 (G93A) transgenic mice without affecting survival.Amyotrophic lateral sclerosis

P2860

Q22299116-395CFD8F-A4F3-4FF5-A6D3-238C558FB1CD Q24202239-D4810949-C576-4099-A853-457C7733BF71 Q24242629-19996F10-0076-439F-8CE1-882A096D3171 Q24633884-47BD88C8-EC42-4222-9B04-01F4BFDA14E6 Q26745618-7DCB23F8-ED1C-48EF-9D2D-24D130A4A2CB Q26777929-96400375-68F7-482F-A342-98D9F12F9574 Q26796027-140FFE79-68A2-44AA-B388-94E5DA1F4EE6 Q34173898-9CC8FE2C-C21C-4753-9AC8-DC04B6CC03BC Q34234907-AD1E7B7E-D277-4CB9-B979-E3610399FD3D Q34449698-42B7B2D5-7E96-47AB-B7C9-95F958C71480 Q35630224-4319A2D9-AA40-4D74-B459-9DE3DEE38FD1 Q38013238-3C9745AB-CEEA-41F8-BA6D-7B2FBDACBCFE Q38269376-1E6CB0BA-0D16-4B33-9304-F2516E6FF786 Q38503842-42FCE8C2-8889-4B20-937D-ADAD064915EE Q38563981-DE4E422A-A4BC-41EB-A4AC-FFD1472BA093 Q38684679-9BD8908C-892A-4B40-BD60-C1CF04359634 Q38892540-565A9288-363C-4756-A52D-0AC57230FD13 Q38996589-5E682B2A-DEF4-44B6-91A8-86AF95D91ED0 Q39135597-440CA66C-D33C-4C17-9528-A5282FBD892D Q39691650-0ABD1C72-9909-4265-9220-37DAC81738CD Q41653374-5E6EA397-A10B-4837-94DD-0833C52B9F6A Q43075467-31955837-C7F6-4A97-9607-4402C651B9AC Q46720336-A5C0A035-4F55-4857-8497-BD1CEE127A6F Q56531747-BCB143D1-7E10-4054-B3E8-C7C971E5A0A4

P2860

Survey of cannabis use in patients with amyotrophic lateral sclerosis.

http://www.wikidata.org/entity/Q39382412

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年学术文章

@wuu

2004年学术文章

@zh-cn

2004年学术文章

@zh-hans

2004年学术文章

@zh-my

2004年学术文章

@zh-sg

2004年學術文章

@yue

2004年學術文章

@zh

2004年學術文章

@zh-hant

name

Survey of cannabis use in patients with amyotrophic lateral sclerosis.

@en

Survey of cannabis use in patients with amyotrophic lateral sclerosis.

@nl

type

label

Survey of cannabis use in patients with amyotrophic lateral sclerosis.

@en

Survey of cannabis use in patients with amyotrophic lateral sclerosis.

@nl

prefLabel

Survey of cannabis use in patients with amyotrophic lateral sclerosis.

@en

Survey of cannabis use in patients with amyotrophic lateral sclerosis.

@nl

P1433

Q39382412-D0B55B1F-3051-467A-AE31-C891777DA1CC

P1476

Q39382412-68BC72DA-8E86-46B3-9590-D02316491437

P2093

Q39382412-21B5F19A-46C8-4EA9-91FB-F33DE92949ED

Q39382412-2F0710F2-600B-4BE7-8785-C5A4F0021EED

Q39382412-A86F5768-19A6-4C6C-A518-83CED4429B85

Q39382412-B4AA257E-79DD-4FB8-B212-9C48B35DE8FB

Q39382412-E92FE7B1-BBB1-4FE0-AC7F-6FAA85B5BC89

P2860

Q39382412-0BCB8D16-9A57-4260-8AF6-F3BD9096DF12

Q39382412-1337D724-F281-4B00-901E-4583191097DF

Q39382412-1A957A85-F51C-4682-AD1D-D72EC3CE78D4

Q39382412-1A98EC9C-68BB-4E43-8948-10CE478CC6B3

Q39382412-21596192-1FFD-4605-8FDC-204BBC602890

Q39382412-26B9CB6F-9EB1-4C06-8F3F-AA3678F752A6

Q39382412-2C75E0C4-FB87-44DE-9B13-24C7C2192E3D

Q39382412-374826EB-CDF5-425B-A374-BA9978546B68

Q39382412-4E982E5F-FF66-4B9F-B813-F997A8817726

Q39382412-520715A2-7F71-44CC-94AA-DF87F7B8947C

P304

Q39382412-C80A4C17-A71E-415A-A05F-E80834B9318C

P31

Q39382412-30441FBE-1F92-4F33-9B49-84BDCA3AD7B2

P356

Q39382412-B6448E4E-3146-4AB6-BA36-C92D998CDB12

P433

Q39382412-2CF11277-0FAE-4F07-9571-0BA81EF568F5

P478

Q39382412-892B88A6-2650-4D0E-BCAD-7AA2BD716DBD

P577

Q39382412-FF1F0920-7021-4674-93B7-FE9E8B462B5F

P698

Q39382412-F3674F76-EB2B-4541-80FD-9976882319B6

P921

Q39382412-53BC15C2-4907-4053-8C2F-DFAB9D768622

Q39382412-EE443B2E-25B8-47F2-B662-254404645AC8

P356

104990910402100206

P1433

American Journal of Hospice and Palliative Medicine

P1476

Survey of cannabis use in patients with amyotrophic lateral sclerosis.

@en

P2093

Dagmar Amtmann

http://www.w3.org/2001/XMLSchema#string

Gregory T Carter

http://www.w3.org/2001/XMLSchema#string

Kurt L Johnson

http://www.w3.org/2001/XMLSchema#string

Mark P Jensen

http://www.w3.org/2001/XMLSchema#string

Patrick Weydt

http://www.w3.org/2001/XMLSchema#string

P2860

Cannabidiol and (-)Delta9-tetrahydrocannabinol are neuroprotective antioxidants

An analgesia circuit activated by cannabinoids

Marijuana in the management of amyotrophic lateral sclerosis.

Expanding the role of hospice care in amyotrophic lateral sclerosis.

Terminal elimination plasma half-life of delta 1-tetrahydrocannabinol (delta 1-THC) in heavy users of marijuana.

Suppression of neuropathic pain behavior in rats by a non-psychotropic synthetic cannabinoid with NMDA receptor-blocking properties.

Effect of cannabinoids on spasticity and ataxia in multiple sclerosis.

The perceived effects of smoked cannabis on patients with multiple sclerosis.

A random walk through a cannabis field.

The analgesic properties of delta-9-tetrahydrocannabinol and codeine.

P304

95-104

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/104990910402100206

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

21

http://www.w3.org/2001/XMLSchema#string

P577

2004-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15055508

http://www.w3.org/2001/XMLSchema#string

P921

amyotrophic lateral sclerosis